Paid Clinical Trials in Anchorage, AK

As of September 2026, 97 paid clinical trials are recruiting in Anchorage, Alaska. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 21, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

94 clinical trials

Get a weekly email when new trials open in Anchorage, AK.

The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals

for Death

Sites in Anchorage, Juneau +17 more locations

Sponsor: Mayo Clinic

Sex: All·Age: 0 Days+

Code: NCT06087224·Recruiting·Listed Oct 2023

Apply to this trial

More Outside Your Door: a Diet/physical Activity Intervention to Decrease Risk of Obesity in Alaska Native Preschoolers

for Child Obesity

1 location in Anchorage

Sponsor: Alaska Native Tribal Health Consortium

Sex: All·Age: 3 - 5·Accepts healthy volunteers

Code: NCT06303544·Recruiting·Listed Mar 2024

Apply to this trial

The Alaska Oculocardiac Reflex Study

for Bradycardia

1 location in Anchorage

Sponsor: Alaska Blind Child Discovery

Sex: All·Age: 1 Month - 100·Accepts healthy volunteers

Code: NCT04353960·Recruiting·Listed Apr 2020

Apply to this trial

Metabolism-Informed Care to Aid Alaska Native People to Quit Smoking (QUIT)

for Smoking Cessation

1 location in Anchorage

Sponsor: Southcentral Foundation

Sex: All·Age: 18+

Code: NCT06556238·Recruiting·Listed Aug 2024

Apply to this trial

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

for Central Line Associated Blood Stream Infections (CLABSI)

Sites in Anchorage +18 more locations

Sponsor: Swedish Medical Center

Sex: All·Age: 18+

Code: NCT07108660·Recruiting·Listed Aug 2025

Apply to this trial

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for Gastric Cancer

Drug: Sonesitatug vedotin

Sites in Anchorage +79 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07431281·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure

for Myeloma Multiple

Drug: Daratumumab

1 location in Anchorage

Sponsor: Eastern Cooperative Oncology Group

Sex: All·Age: 18+

Code: NCT07085728·Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

for HER2-positive Gastric Cancer

Drug: Rilvegostomig

Sites in Anchorage +45 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06764875·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

for Endometrial Carcinoma

Sites in Anchorage +327 more locations

Sponsor: National Cancer Institute (NCI)

Sex: Female·Age: 18+

Code: NCT05256225·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

for Untreated Follicular Lymphoma

Drug: Rituximab

Sites in Anchorage +56 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT06549595·Phase 3·Recruiting·Listed Aug 2024

Apply to this trial

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

for Asthma

Sites in Anchorage +95 more locations

Sponsor: AstraZeneca

Sex: All·Age: 12 - 17

Code: NCT06307665·Phase 3·Recruiting·Listed Mar 2024

Apply to this trial

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for Non-Small Cell Lung Cancer

Drug: Rilvegostomig

Sites in Anchorage +48 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06357533·Phase 3·Recruiting·Listed Apr 2024

Apply to this trial